Clinical trials - Press Releases

Date	Title	Company
27-May-2022	Transgene to Present Updated Positive Preliminary Data from the Phase I Clinical Trials with TG4050 (myvac® platform) at ASCO 2022	Transgene
27-May-2022	4D pharma presents trial in progress poster on the Phase II Study of MRx0518 in combination with BAVENCIO(R) in patients with unresectable locally advanced or metastatic urothelial carcinoma at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting	4D pharma plc
27-May-2022	Elevar Therapeutics Announces Rivoceranib Demonstrated Clinical Effectiveness in Patients with Progressive Recurrent or Metastatic Adenoid Cystic Carcinoma in a Phase 2 Trial	Elevar Therapeutics
26-May-2022	UCB Announces First Detailed Data from Two Phase 3 Bimekizumab Studies in Psoriatic Arthritis to be Presented at EULAR 2022	UCB
26-May-2022	AlzeCure gets approval to start Phase II clinical trial with non-opioid pain project ACD440	AlzeCure Pharma AB
25-May-2022	uMotif – the patient-first data capture and decentralized clinical trials platform – announces $25.5m of new investment from a fund managed by Athyrium Capital Management	uMotif
25-May-2022	PrecisionLife Wins Analytics Company of the Year at British Data Awards	PrecisionLife
25-May-2022	Neonatal Diagnostics Company InfanDx AG Completes Two-Year Patient Follow-Up in BANON Study	InfanDx AG
24-May-2022	First Presentations of Phase 3 Data for Bimekizumab Across the Full Spectrum of Axial Spondyloarthritis to be Shared at EULAR 2022	UCB
24-May-2022	Point of Care Diagnostic Market Worth $73,293 Million by 2031: Visiongain Research Inc	Visiongain
23-May-2022	Global Vaccine Contract Manufacturing market is projected to grow at a CAGR of 11.18% By 2032: Visiongain Research Inc	Visiongain
20-May-2022	SAE Media Group Announces the date for 2nd Annual Aseptic Processing Conference	SAE Media Group
19-May-2022	mdgroup Growth sees New VP, Product Delivery, Investing for the Future	mdgroup
19-May-2022	IAVI and Moderna Launch First-in-Africa Clinical Trial of mRNA HIV Vaccine Development Program	IAVI and Moderna, Inc.
19-May-2022	Patient Centricity, AI-Powered Insights and Diversity in Clinical Trials Among Key Topics at Medidata NEXT London	Medidata
18-May-2022	Successful Completion of Phase I Study for Lead Asset EP395	EpiEndo Pharmaceuticals
17-May-2022	N4 Pharma highlights potential of Nuvec® as gene therapy delivery platform	N4 Pharma
17-May-2022	PureTech Presents Additional Phase 1 Data for LYT-100 at American Thoracic Society 2022	PureTech
17-May-2022	4D pharma presents late breaking abstract from Phase I/II trial of MRx-4DP0004 for the treatment of asthma at the American Thoracic Society (ATS) 2022 International Conference	4D pharma
17-May-2022	PT027, a novel fixed-dose combination of albuterol and budesonide, used as an as-needed rescue medicine, significantly reduced the risk of a severe exacerbation compared to albuterol by 27% in patients with asthma	AstraZeneca